Stay updated on Extension Study for KarXT Safety in Schizophrenia Clinical Trial

Sign up to get notified when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:22:55.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    6 days ago
    Change Detected
    Summary
    The value of Last Update Posted (Estimated) has been updated to Last Update Posted. This change indicates that the last update for the study record was posted on a specific date.
    Difference
    0.1%
    Check dated 2024-06-10T20:08:09.000Z thumbnail image
  7. Check
    9 days ago
    Change Detected
    Summary
    The value 2024-03-22 Last Update Posted has recently changed to 2024-06-07. Additionally, new clinical trial sites have been added in Orange, California, Pico Rivera, California, Miami Springs, Florida, Saint Louis, Missouri, Richardson, Texas, Dupnitsa, Bulgaria, Pleven, Bulgaria, Sliven, Bulgaria, and Vratsa, Bulgaria.
    Difference
    5%
    Check dated 2024-06-07T16:09:10.000Z thumbnail image
  8. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating an update in the study record related to the long-term safety and tolerability assessment of adjunctive KarXT in subjects with schizophrenia. This change reflects a modification in the primary objective of the Phase 3 clinical trial.
    Difference
    0.1%
    Check dated 2024-06-06T14:36:36.000Z thumbnail image
  9. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying age, prior treatment completion, compliance, and other health-related conditions. This change provides more specific information about the requirements for individuals to participate in the study.
    Difference
    37%
    Check dated 2024-05-22T21:36:18.000Z thumbnail image
  10. Check
    46 days ago
    Change Detected
    Difference
    1.0%
    Check dated 2024-04-30T22:39:10.000Z thumbnail image

Stay in the know with updates to Extension Study for KarXT Safety in Schizophrenia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.